| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Revenue | $5.9M | +6.1% |
| Cost of Revenue | $4.2M | +55.7% |
| Gross Profit | $1.7M | -41.3% |
| R&D Expense | $3.6M | -53.2% |
| Operating Income | -$21.7M | +26.1% |
| Pre-tax Income | -$22.5M | +21.5% |
| Income Tax | -$1.0M | +17.5% |
| Net Income | -$21.5M | +21.7% |
| EPS (Basic) | -$0.17 |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.7M | +113.1% |
| Accounts Receivable | $1.2M | +49.6% |
| Inventory | $4.2M | -12.6% |
| Current Assets | $13.6M | +29.1% |
| Total Assets | $30.8M | +7.3% |
| Current Liabilities | $3.3M | -55.3% |
| Total Liabilities | $4.1M | -55.8% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.6M | +37.4% |
| Capital Expenditures | $505K | -80.5% |
| Investing Cash Flow | -$505K | -102.0% |
| Financing Cash Flow | $22.7M | +4740.7% |
| Free Cash Flow | -$19.1M | +40.8% |
| +63.8% |
| EPS (Diluted) | -$0.17 | +63.8% |
| Stockholders' Equity |
| $26.7M |
| +37.8% |